Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling

J Biol Chem. 2001 Jun 15;276(24):21489-99. doi: 10.1074/jbc.M009382200. Epub 2001 Mar 21.

Abstract

Glucagon-like peptide-2 (GLP-2) regulates energy homeostasis via effects on nutrient absorption and maintenance of gut mucosal epithelial integrity. The biological actions of GLP-2 in the central nervous system (CNS) remain poorly understood. We studied the sites of endogenous GLP-2 receptor (GLP-2R) expression, the localization of transgenic LacZ expression under the control of the mouse GLP-2R promoter, and the actions of GLP-2 in the murine CNS. GLP-2R expression was detected in multiple extrahypothalamic regions of the mouse and rat CNS, including cell groups in the cerebellum, medulla, amygdala, hippocampus, dentate gyrus, pons, cerebral cortex, and pituitary. A 1.5-kilobase fragment of the mouse GLP-2R promoter directed LacZ expression to the gastrointestinal tract and CNS regions in the mouse that exhibited endogenous GLP-2R expression, including the cerebellum, amygdala, hippocampus, and dentate gyrus. Intracerebroventricular injection of GLP-2 significantly inhibited food intake during dark-phase feeding in wild-type mice. Disruption of glucagon-like peptide-1 receptor (GLP-1R) signaling with the antagonist exendin-(9-39) in wild-type mice or genetically in GLP-1R(-)/- mice significantly potentiated the anorectic actions of GLP-2. These findings illustrate that CNS GLP-2R expression is not restricted to hypothalamic nuclei and demonstrate that the anorectic effects of GLP-2 are transient and modulated by the presence or absence of GLP-1R signaling in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amygdala / drug effects
  • Amygdala / physiology
  • Animals
  • Base Sequence
  • Brain / drug effects
  • Brain / physiology*
  • Cell Line
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology
  • Gastrointestinal Hormones / pharmacology
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Injections, Intraventricular
  • Male
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Organ Specificity
  • Peptides / administration & dosage
  • Peptides / pharmacology*
  • Pituitary Gland / drug effects
  • Pituitary Gland / physiology
  • Promoter Regions, Genetic
  • RNA, Messenger / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glucagon / drug effects
  • Receptors, Glucagon / genetics*
  • Receptors, Glucagon / physiology*
  • Recombinant Proteins / drug effects
  • Recombinant Proteins / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Alignment
  • Sequence Homology, Nucleic Acid
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Transfection
  • beta-Galactosidase / analysis
  • beta-Galactosidase / genetics

Substances

  • GLP1R protein, human
  • Gastrointestinal Hormones
  • Glp1r protein, mouse
  • Glp1r protein, rat
  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptide-1 Receptor
  • Peptides
  • RNA, Messenger
  • Receptors, Glucagon
  • Recombinant Proteins
  • Glucagon-Like Peptide 1
  • beta-Galactosidase

Associated data

  • GENBANK/AF338223
  • GENBANK/AF338224